Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jane Armitage is Professor of Clinical Trials and Epidemiology and Honorary Consultant in Public Health Medicine. She is also Director of Training and Career Development for Oxford Population Health.

She joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 1990, having qualified in clinical medicine in 1979. Jane worked in a variety of specialties over several years with particular experience in respiratory medicine, geriatrics and diabetes.

Since joining CTSU she has coordinated and been chief investigator for a series of large-scale randomised clinical trials in cardiovascular disease including the 20,000 participant MRC/BHF Heart Protection Study, the 12,000 patient SEARCH and 25,000 HPS2-THRIVE study, which are trials of lipid modification in people with or at risk of vascular disease.

In addition she is Chief Investigator for the BHF-supported ASCEND trial of aspirin and fish oils involving 15,000 people with diabetes. She collaborates with other epidemiologists and statisticians at Oxford Population Health on a variety of genetic and other risk factor studies based on the trial cohorts.

 

This seminar is open to members of the University. 

Forthcoming events

Will the next pandemic be caused by H5N1 influenza?

Monday, 02 June 2025, 1pm to 2pm @ Richard Doll Lecture Theatre

The world is currently experiencing a panzootic of H5N1 influenza. Wild birds have carried the virus across all continents and an unprecedented number of mammalian species have been infected including humans. What will it take for this virus to go pandemic, and does the introduction of the virus into dairy herds in USA bring that one step closer? Wendy will discuss the current knowledge on host range barriers that protect us from more frequent zoonoses and pandemic from bird flu, and show how we can use this scientific knowledge to risk assess the current situation.

Better treatment for tuberculosis

Monday, 09 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Resolving the genetic basis of type 2 diabetes in 125 000 Mexicans

Tuesday, 10 June 2025, 1pm to 2pm @ Richard Doll Lecture Theatre

The burden of drug resistant infections, the GRAM project

Monday, 16 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Large scale genetic consortia

Tuesday, 17 June 2025, 1pm to 2pm @ Richard Doll lecture theatre